PINK1 phosphorylates transglutaminase 2 and blocks its proteasomal degradation

Journal of Neuroscience Research

Volumn 93, Issue 5, 2015, Pages 722-735

  Min, Boram ^a   Kwon, Young Chang ^a   Choe, Kwang Min ^a   Chung, Kwang Chul ^a  

^a Yonsei University   (South Korea)

Author keywords

Parkinson's disease; Phosphorylation; PINK1; Transglutaminase 2; Ubiquitination

Indexed keywords

CARBONYL CYANIDE CHLOROPHENYLHYDRAZONE; PINK1 PROTEIN; PROTEASOME; PROTEIN GLUTAMINE GAMMA GLUTAMYLTRANSFERASE 2; PROTEIN SERINE THREONINE KINASE; UNCLASSIFIED DRUG; GUANINE NUCLEOTIDE BINDING PROTEIN; MESSENGER RNA; PROTEIN GLUTAMINE GAMMA GLUTAMYLTRANSFERASE; PROTEIN KINASE; PROTON IONOPHORE; PTEN-INDUCED PUTATIVE KINASE;

ANIMAL TISSUE; ARTICLE; CELL DAMAGE; DROSOPHILA MELANOGASTER; ENZYME DEGRADATION; HALF LIFE TIME; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; PROTEIN STABILITY; UBIQUITINATION; ANIMAL; CELL LINE; CELL ORGANELLE; CHEMISTRY; DRUG EFFECTS; ENZYME ACTIVATION; GENETIC TRANSFECTION; GENETICS; IMMUNOPRECIPITATION; METABOLISM; PHYSIOLOGY; POINT MUTATION; PROTEIN TERTIARY STRUCTURE; RNA INTERFERENCE; TRANSGENIC MOUSE;

ANIMALS; CARBONYL CYANIDE M-CHLOROPHENYL HYDRAZONE; CELL LINE; DROSOPHILA MELANOGASTER; ENZYME ACTIVATION; GTP-BINDING PROTEINS; HUMANS; IMMUNOPRECIPITATION; MICE; MICE, TRANSGENIC; ORGANELLES; POINT MUTATION; PROTEASOME ENDOPEPTIDASE COMPLEX; PROTEIN KINASES; PROTEIN STRUCTURE, TERTIARY; PROTON IONOPHORES; RNA INTERFERENCE; RNA, MESSENGER; TRANSFECTION; TRANSGLUTAMINASES; UBIQUITINATION;

EID: 84925689701     PISSN: 03604012     EISSN: 10974547     Source Type: Journal    
DOI: 10.1002/jnr.23535     Document Type: Article

References (39)

1. Begg GE, Holman SR, Stokes PH, Matthews JM, Graham RM, Iismaa SE. 2006. Mutation of a critical arginine in the GTP-binding site of transglutaminase 2 disinhibits intracellular cross-linking activity. J Biol Chem 281:12603-12609.
2. Beilina A, Van Der Brug M, Ahmad R, Kesavapany S, Miller DW, Petsko GA, Cookson MR. 2005. Mutations in PTEN-induced putative kinase 1 associated with recessive parkinsonism have differential effects on protein stability. Proc Natl Acad Sci U S A 102:5703-5708.
3. Belin AC, Westerlund M. 2008. Parkinson's disease: a genetic perspective. FEBS J 275:1377- 1383.
4. Brand AH, Perrimon N. 1993. Targeted gene expression as a means of altering cell fates and generating dominant phenotypes. Development 118:401-415.
5. Choi I, Kim J, Jeong HK, Kim B, Jou I, Park SM, Chen L, Kang UJ, Zhuang X, Joe EH. 2013. PINK1 deficiency attenuates astrocyte proliferation through mitochondrial dysfunction, reduced AKT and increased p38 MAPK activation, and downregulation of EGFR. Glia 61:800-812.
6. Clark IE, Dodson MW, Jiang C, Cao JH, Huh JR, Seol JH, Yoo SJ, Hay BA, Guo M. 2006. Drosophila pink1 is required for mitochondrial function and interacts genetically with parkin. Nature 441:1162-1166.
7. Collighan RJ, Griffin M. 2009. Transglutaminase 2 cross-linking of matrix proteins: biological significance and medical applications. Amino Acids 36:659-670.
8. D'Eletto M, Farrace MG, Rossin F, Strappazzon F, Giacomo GD, Cecconi F, Melino G, Sepe S, Moreno S, Fimia GM, Falasca L, Nardacci R, Piacentini M. 2012. Type 2 transglutaminase is involved in the autophagy-dependent clearance of ubiquitinated proteins. Cell Death Differ 19:1228-1238.
9. Ichikawa A, Yamada A, Sakamoto H, Umehara M, Yoshioka Y, Yamaguchi M, Ikura K. 2010. Overexpression of transglutaminase in the Drosophila wing imaginal disc induced an extra wing crossvein phenotype. Biosci Biotechnol Biochem 74:2494-2496.
10. Jeong EM, Kim CW, Cho SY, Jang GY, Shin DM, Jeon JH, Kim IG. 2009. Degradation of transglutaminase 2 by calcium-mediated ubiquitination responding to high oxidative stress. FEBS Lett 583:648-654.
11. Junn E, Ronchetti RD, Quezado MM, Kim SY, Mouradian MM. 2003. Tissue transglutaminase-induced aggregation of alpha-synuclein: implications for Lewy body formation in Parkinson's disease and dementia with Lewy bodies. Proc Natl Acad Sci U S A 100:2047-2052.
12. Kitada T, Pisani A, Porter DR, Yamaguchi H, Tscherter A, Martella G, Bonsi P, Zhang C, Pothos EN, Shen J. 2007. Impaired dopamine release and synaptic plasticity in the striatum of PINK1-deficient mice. Proc Natl Acad Sci U S A 104:11441-11446.
13. Klein C, Westenberger A. 2012. Genetics of Parkinson's disease. Cold Spring Harbor Perspect Med 2:a008888.
14. Kondapalli C, Kazlauskaite A, Zhang N, Woodroof HI, Campbell DG, Gourlay R, Burchell L, Walden H, Macartney TJ, Deak M, Knebel A, Alessi DR, Muqit MM. 2012. PINK1 is activated by mitochondrial membrane potential depolarization and stimulates Parkin E3 ligase activity by phosphorylating Serine 65. Open Biol 2:120080.
15. Lai TS, Davies C, Greenberg CS. 2010. Human tissue transglutaminase is inhibited by pharmacologic and chemical acetylation. Protein Sci 19:229-235.
16. Lee HJ, Jang SH, Kim H, Yoon JH, Chung KC. 2012. PINK1 stimulates interleukin-1beta-mediated inflammatory signaling via the positive regulation of TRAF6 and TAK1. Cell Mol Life Sci 69:3301-3315.
17. Malorni W, Farrace MG, Matarrese P, Tinari A, Ciarlo L, Mousavi-Shafaei P, D'Eletto M, Di Giacomo G, Melino G, Palmieri L, Rodolfo C, Piacentini M. 2009. The adenine nucleotide translocator 1 acts as a type 2 transglutaminase substrate: implications for mitochondrial-dependent apoptosis. Cell Death Differ 16:1480-1492.
18. Matsuda N, Sato S, Shiba K, Okatsu K, Saisho K, Gautier CA, Sou YS, Saiki S, Kawajiri S, Sato F, Kimura M, Komatsu M, Hattori N, Tanaka K. 2010. PINK1 stabilized by mitochondrial depolarization recruits Parkin to damaged mitochondria and activates latent Parkin for mitophagy. J Cell Biol 189:211-221.
19. Muqit MM, Abou-Sleiman PM, Saurin AT, Harvey K, Gandhi S, Deas E, Eaton S, Payne Smith MD, Venner K, Matilla A, Healy DG, Gilks WP, Lees AJ, Holton J, Revesz T, Parker PJ, Harvey RJ, Wood NW, Latchman DS. 2006. Altered cleavage and localization of PINK1 to aggresomes in the presence of proteasomal stress. J Neurochem 98:156-169.
20. Nemes Z, Petrovski G, Aerts M, Sergeant K, Devreese B, Fesus L. 2009. Transglutaminase-mediated intramolecular cross-linking of membrane-bound alpha-synuclein promotes amyloid formation in Lewy bodies. J Biol Chem 284:27252-27264.
21. Olanow CW, Tatton WG. 1999. Etiology and pathogenesis of Parkinson's disease. Annu Rev Neurosci 22:123-144.
22. Park J, Lee SB, Lee S, Kim Y, Song S, Kim S, Bae E, Kim J, Shong M, Kim JM, Chung J. 2006. Mitochondrial dysfunction in Drosophila PINK1 mutants is complemented by parkin. Nature 441:1157-1161.
23. Pridgeon JW, Olzmann JA, Chin LS, Li L. 2007. PINK1 protects against oxidative stress by phosphorylating mitochondrial chaperone TRAP1. PLoS Biol 5:e172.
24. Shibata T, Ariki S, Shinzawa N, Miyaji R, Suyama H, Sako M, Inomata N, Koshiba T, Kanuka H, Kawabata S. 2010. Protein crosslinking by transglutaminase controls cuticle morphogenesis in Drosophila. PloS One 5:e13477.
25. Shin DM, Jeon JH, Kim CW, Cho SY, Kwon JC, Lee HJ, Choi KH, Park SC, Kim IG. 2004. Cell type-specific activation of intracellular transglutaminase 2 by oxidative stress or ultraviolet irradiation: implications of transglutaminase 2 in age-related cataractogenesis. J Biol Chem 279:15032-15039.
26. Silvestri L, Caputo V, Bellacchio E, Atorino L, Dallapiccola B, Valente EM, Casari G. 2005. Mitochondrial import and enzymatic activity of PINK1 mutants associated to recessive parkinsonism. Hum Mol Genet 14:3477-3492.
27. Tai HR, Jiang CA. 2013. [The mechanism of PINK1 localization on the outer membrane of mitochondria]. Sichuan Da Xue Xue Bao Yi Xue Ban 44:179-183.
28. Um JW, Stichel-Gunkel C, Lubbert H, Lee G, Chung KC. 2009. Molecular interaction between parkin and PINK1 in mammalian neuronal cells. Mol Cell Neurosci 40:421-432.
29. Um JW, Park HJ, Song J, Jeon I, Lee G, Lee PH, Chung KC. 2010. Formation of parkin aggregates and enhanced PINK1 accumulation during the pathogenesis of Parkinson's disease. Biochem Biophys Res Commun 393:824-828.
30. Umehara M, Ichikawa A, Sakamoto H, Yamada A, Yoshioka Y, Yamaguchi M, Ikura K. 2010. Over-expression of transglutaminase in the Drosophila eye imaginal disc induces a rough eye phenotype. Mol Cell Biochem 342:223-232.
31. Valente EM, Abou-Sleiman PM, Caputo V, Muqit MM, Harvey K, Gispert S, Ali Z, Del Turco D, Bentivoglio AR, Healy DG, Albanese A, Nussbaum R, Gonzalez-Maldonado R, Deller T, Salvi S, Cortelli P, Gilks WP, Latchman DS, Harvey RJ, Dallapiccola B, Auburger G, Wood NW. 2004. Hereditary early-onset Parkinson's disease caused by mutations in PINK1. Science 304:1158-1160.
32. +-treated human SH-SY5Y cells. Neurochem Int 62:486-491.
33. Vives-Bauza C, Zhou C, Huang Y, Cui M, de Vries RL, Kim J, May J, Tocilescu MA, Liu W, Ko HS, Magrane J, Moore DJ, Dawson VL, Grailhe R, Dawson TM, Li C, Tieu K, Przedborski S. 2010. PINK1-dependent recruitment of Parkin to mitochondria in mitophagy. Proc Natl Acad Sci U S A 107:378-383.
34. Wang D, Qian L, Xiong H, Liu J, Neckameyer WS, Oldham S, Xia K, Wang J, Bodmer R, Zhang Z. 2006. Antioxidants protect PINK1-dependent dopaminergic neurons in Drosophila. Proc Natl Acad Sci U S A 103:13520-13525.
35. Wang X, Winter D, Ashrafi G, Schlehe J, Wong YL, Selkoe D, Rice S, Steen J, LaVoie MJ, Schwarz TL. 2011. PINK1 and Parkin target Miro for phosphorylation and degradation to arrest mitochondrial motility. Cell 147:893-906.
36. Wang Y, Ande SR, Mishra S. 2012. Phosphorylation of transglutaminase 2 (TG2) at serine-216 has a role in TG2 mediated activation of nuclear factor-kappa B and in the downregulation of PTEN. BMC Cancer 12:277.
37. Whitworth AJ, Lee JR, Ho VM, Flick R, Chowdhury R, McQuibban GA. 2008. Rhomboid-7 and HtrA2/Omi act in a common pathway with the Parkinson's disease factors Pink1 and Parkin. Dis Model Mech 1:168-174.
38. Yoo JO, Lim YC, Kim YM, Ha KS. 2012. Transglutaminase 2 promotes both caspase-dependent and caspase-independent apoptotic cell death via the calpain/Bax protein signaling pathway. J Biol Chem 287:14377-14388.
39. Zhou C, Huang Y, Shao Y, May J, Prou D, Perier C, Dauer W, Schon EA, Przedborski S. 2008. The kinase domain of mitochondrial PINK1 faces the cytoplasm. Proc Natl Acad Sci U S A 105:12022-12027.